» Authors » James Loughead

James Loughead

Explore the profile of James Loughead including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 4303
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi Z, Li X, Todaro D, Cao W, Lynch K, Detre J, et al.
Transl Psychiatry . 2024 Sep; 14(1):360. PMID: 39237534
Opioid use disorder (OUD) has been linked to macroscopic structural alterations in the brain. The monthly injectable, extended-release formulation of μ-opioid antagonist naltrexone (XR-NTX) is highly effective in reducing opioid...
2.
Metcalf C, Page C, Stocker B, Johnson R, Duffy K, Sammel M, et al.
Gynecol Oncol . 2024 Aug; 190:62-69. PMID: 39146756
Objective: To determine whether the psychostimulant lisdexamfetamine improves subjective and objective measures of cognitive functioning among women genetically at-risk for cancer who have undergone risk-reducing salpingo-oophorectomy and report new-onset executive...
3.
Page C, Soreth B, Metcalf C, Johnson R, Duffy K, Sammel M, et al.
Focus (Am Psychiatr Publ) . 2024 May; 22(1):97-108. PMID: 38694151
Objective: The menopause transition is associated with difficulties in executive function. However, it is unclear whether these difficulties persist past perimenopause. This study investigated whether potential confounders, including natural vs....
4.
Jacobs P, Jee J, Fang L, Devlin E, Iannelli C, Thakuri D, et al.
PLoS One . 2024 Feb; 19(2):e0297310. PMID: 38363747
Introduction: With nicotine dependence being a significant healthcare issue worldwide there is a growing interest in developing novel therapies and diagnostic aids to assist in treating nicotine addiction. Glutamate (Glu)...
5.
Shi Z, Wang A, Liu J, Audrain-McGovern J, Lynch K, Loughead J, et al.
medRxiv . 2024 Jan; PMID: 38260670
Introduction: Graphic warning labels (GWLs) are widely employed to communicate smoking-related health risks; however, their implementation in the US has been held back by concerns about their efficacy. Most GWLs...
6.
Wanger T, de Moura F, Ashare R, Loughead J, Lukas S, Lerman C, et al.
Addict Biol . 2023 Nov; 28(12):e13338. PMID: 38017638
Cues associated with smoking can induce relapse, which is likely driven by cue-induced neurobiological and physiological mechanisms. For instance, greater relapse vulnerability is associated with increases in cue-induced insula activation...
7.
Chao A, Wadden T, Cao W, Zhou Y, Maldonado D, Cardel M, et al.
Nurs Res . 2023 Nov; 73(2):91-100. PMID: 37916843
Background: It is not known whether behavioral weight loss can attenuate blood oxygen level-dependent responses to food stimuli. Objectives: This randomized controlled trial assessed the effects of a commercially available...
8.
Greene B, Bernardo L, Thompson M, Loughead J, Ashare R
JMIR Form Res . 2023 Jul; 7:e47121. PMID: 37477975
Background: Nearly 1 in 3 clinical trials end prematurely due to underenrollment. Strategies to enhance recruitment are often implemented without scientific rigor to evaluate efficacy. Evidence-based, cost-effective behavioral economic strategies...
9.
Page C, Soreth B, Metcalf C, Johnson R, Duffy K, Sammel M, et al.
Maturitas . 2023 Feb; 170:64-73. PMID: 36806931
Objective: The menopause transition is associated with difficulties in executive function. However, it is unclear whether these difficulties persist past perimenopause. This study investigated whether potential confounders, including natural vs....
10.
Shi Z, Li X, Byanyima J, OBrien C, Childress A, Lynch K, et al.
Am J Drug Alcohol Abuse . 2023 Feb; 49(2):180-189. PMID: 36787540
Cigarette smoking (CS) and opioid use disorder (OUD) significantly alter brain structure. Although OUD and cigarette smoking are highly comorbid, most prior neuroimaging research in OUD did not control for...